Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Emicizumab Treatment on the Musculoskeletal System in Children With Hemophilia A: A Prospective Study

NCT07190118 is registered in ClinicalTrials.gov with Hasan Kalyoncu University as lead sponsor.

NCT NCT07190118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07190118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Emicizumab Treatment on the Musculoskeletal System in Children With Hemophilia A: A Prospective Study
Lead sponsor
Hasan Kalyoncu University
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
February 10, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemophilia a, musculoskeletal abnormalities, musculoskeletal assessment